Table: begin end state 1 5 non-cytoplasmic 6 24 transmembrane 25 34 cytoplasmic 35 59 transmembrane 60 64 non-cytoplasmic 65 83 transmembrane 84 103 cytoplasmic 104 135 transmembrane 136 140 non-cytoplasmic 141 168 transmembrane 169 177 cytoplasmic 178 196 transmembrane 197 203 non-cytoplasmic 204 226 transmembrane 227 237 cytoplasmic 238 258 transmembrane 259 263 non-cytoplasmic 264 281 transmembrane 282 325 cytoplasmic 326 343 transmembrane 344 372 non-cytoplasmic 373 391 transmembrane 392 409 cytoplasmic 410 427 transmembrane 428 446 non-cytoplasmic 447 471 transmembrane 472 499 cytoplasmic 500 530 transmembrane 531 533 non-cytoplasmic 534 541 cytoplasmic 542 561 transmembrane 562 564 cytoplasmic 565 565 non-cytoplasmic
Input: >WP_028316862.1 NCBI__GCF_000429905.1:WP_028316862.1 MSIGFLAIAACVPILVALVLMVWMHWPAVRAMPMAWAVCAVLAVAVWKMPVGFVLAATLG GFGNTLNILIIIFGAIVLLFSLQESGGMETIKQGIGGLSDDKRVQILLIAFLFSAFLEGA AGFGTPAAIAAPLLISLGFPALAAVMACLILNSFPVTFGVIGAVVWFGLKNLTPLVNSAA AQGIAPASIPDAWAFFGVVGKWGAVLNTLPIFILPLFVICFVTRYFGANRSWKEGLGAWK ISLFASACFAAAYLFFAFVMGIEFPSLMGGLIALAMTVFAVKQKWLLPANTWTFGPKEQW EKDWIGSIDMNGGGQNAANMSQMRAWAPYILIGALLMLTRLSSLPFKSWVMGLEINIPAI MGYESVNFSMKPFYLPGIMPFMLTALLIVPMHGMSWKKAGVAWSNALKRIIGPALALMFA VALVEIFKQSAHNALDYPSMPLSMAKGAAALAGGAWPLFASFVGALGAFITGSNTVSNLL FSEFQYGLAEQMHLPRQIIVALQLVGGSMGNMVCIHNIVAASAVVGLTGAEGAIIKRNSV PLLIYGLCTGLLGMLFCYVLFPGIF
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server